Drug Database
Back to search

Germany· DE-A57-98f19e19ba4140e8

Radelumin

A medicinal product containing (3s,10s,14s)-1-[4-[[(2s)-4-carboxy-2-[(2s)-4-carboxy-2-(6-[18f] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid, registered in Germany by Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedRadeluminATC—REGISTER NO.DE-A57-98f19e19ba4140…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about (3s,10s,14s)-1-[4-[[(2s)-4-carboxy-2-[(2s)-4-carboxy-2-(6-[18f] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

EMA Article 57 (European Union)
Active substance
(3s,10s,14s)-1-[4-[[(2s)-4-Carboxy-2-[(2s)-4-Carboxy-2-(6-[18f] Fluoropyridin-3-Amido)butanamido]butanamido]methyl]phenyl]-3-[(Naphthalen-2-Yl)methyl]-1,4,12-Trioxo-2,5,11,13-Tetraazahexadecane-10,14,16-Tricarboxylic Acid
Manufacturer
Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

(3s,10s,14s)-1-[4-[[(2s)-4-carboxy-2-[(2s)-4-carboxy-2-(6-[18f] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All (3s,10s,14s)-1-[4-[[(2s)-4-carboxy-2-[(2s)-4-carboxy-2-(6-[18f] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Radelumin
  • Belgium · Radelumin
  • Spain · Radelumin
  • France · Radelumin
  • Greece · Próstalumin
  • Iceland · Axumin
  • Italy · Radelumin
  • Liechtenstein · Axumin
  • Luxembourg · Radelumin
  • Netherlands · Radelumin
  • Norway · Axumin
  • Poland · Radelumin
  • Portugal · Radelumin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/85d99384-7be2-43ac-ae82-64eacfa1497e
GET /v1/drugs/85d99384-7be2-43ac-ae82-64eacfa1497e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "(3s,10s,14s)-1-[4-[[(2s)-4-Carboxy-2-[(2s)-4-Carboxy-2-(6-[18f] Fluoropyridin-3-Amido)butanamido]butanamido]methyl]phenyl]-3-[(Naphthalen-2-Yl)methyl]-1,4,12-Trioxo-2,5,11,13-Tetraazahexadecane-10,14,16-Tricarboxylic Acid",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about (3s,10s,14s)-1-[4-[[(2s)-4-carboxy-2-[(2s)-4-carboxy-2-(6-[18f] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console